Predict your next investment

Diversified Financial Services
laurioncap.com

See what CB Insights has to offer

Investments

12

Portfolio Exits

6

About Laurion Capital Management

Laurion Capital Management is an investment firm. The firm has developed a presence in many of the global capital markets and manages assets on behalf of foundations, endowments, family offices, pension funds, and other institutional and individual investors.

Laurion Capital Management Headquarter Location

360 Madison Avenue Suite 1900

New York, New York, 10017,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Laurion Capital Management News

TRexBio: Closes $26M Series A Extension Funding

Mar 12, 2022

TRexBio Closes $26M Series A Extension Funding TrexBio , a South San Francisco, CA-based discovery stage biotech company, raised $26M in Series A extension funding The round, which brings the total Series A funding raised to $85m, was led by Polaris Partners and Laurion Capital In conjunction with the financing, Alexandra Cantley, Ph.D., Partner at Polaris Partners will join the company’s Board of Directors Alexander Duncan, Ph.D., Biotech Associate at Laurion Capital Management also joins as a Board Observer The company intends to use the funds for the continued expansion of its platform and the advancement of multiple programs through pre-IND activities The company is advancing multiple preclinical programs Tags:

Laurion Capital Management Investments

12 Investments

Laurion Capital Management has made 12 investments. Their latest investment was in TRexBio as part of their Series A - II on March 3, 2022.

CBI Logo

Laurion Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/8/2022

Series A - II

TRexBio

$26M

Yes

6

2/24/2022

Series D

Scipher Medicine

$110M

Yes

12

2/17/2022

Series E

Synthego

$200M

Yes

16

12/21/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

10/12/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/8/2022

2/24/2022

2/17/2022

12/21/2021

10/12/2021

Round

Series A - II

Series D

Series E

Series A - II

Series B

Company

TRexBio

Scipher Medicine

Synthego

Subscribe to see more

Subscribe to see more

Amount

$26M

$110M

$200M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

12

16

10

10

Laurion Capital Management Portfolio Exits

6 Portfolio Exits

Laurion Capital Management has 6 portfolio exits. Their latest portfolio exit was PepGen on May 06, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/6/2022

IPO

1

10/8/2021

IPO

Subscribe to see more

Subscribe to see more

10

10/1/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

2/6/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/6/2022

10/8/2021

10/1/2021

4/16/2021

2/6/2020

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.